Biosimilars: Where Do We Stand?

Event Details
Contact

Karen Manno

Summaries

Summary Sentence: A Georgia Bio luncheon seminar

Full Summary: Biosimilars: Where Do We Stand? - A Georgia Bio luncheon seminar

Biosimilars, also known as follow-on biologics, may eventually expand access and provide patients a more affordable alternative to innovative, lifesaving medicines. However, what are the ethical implications of these products?  How will they impact clinical supply chain?  What are the financial implications?  Join a panel of experts as they explore these and other questions on biosimilars during this luncheon seminar.
Panelists:

Amir Emamifar, PharmD - Associate Administrator Pharmaceutical Services, Emory Healthcare
Yaniv Heled, JSD, LLM - Assistant Professor of Law, Georgia State University College of Law
Ashish Dugar PhD, MBA - Head, Medicines Development Group, Biosimilars Business Unit, Pfizer

Moderator:
Joel Zivot, MD, FRCP – Assistant Professor Anesthesiology & Surgery, Emory University School of Medicine, and Medical Director, Cardiothoracic ICU, Emory University Hospital Midtown

ACHE CEUs:
1.5 hours ACHE Qualified Education Credit (formerly “Category 2”)

Download the Flyer for more details & speaker biographies

Registration:

Registrations for this event are being collected by the Georgia Association of Healthcare Executives. CLICK HERE TO REGISTER.

ACHE/GaBio Member ..... $35
Non-Member ................ $45
Student Member .......... $20
Student Non-Member..... $25

For information contact: GAHE Administrator Karen Manno or call 678-264-8354

A joint program with the Georgia Association of Healthcare Executives

Related Links

Additional Information

In Campus Calendar
No
Groups

Parker H. Petit Institute for Bioengineering and Bioscience (IBB)

Invited Audience
No audiences were selected.
Categories
Seminar/Lecture/Colloquium
Keywords
Biosimilars Where Do We Stand, Georgia Bio
Status
  • Created By: Colly Mitchell
  • Workflow Status: Published
  • Created On: Sep 17, 2012 - 10:52am
  • Last Updated: Oct 7, 2016 - 9:59pm